For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
5
views
3
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    0
    shares
      190
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Assurer la continuité des soins au temps de la COVID-19 : défis pour le centre de traitement des addictions à Dakar Translated title: Ensuring continuity of care at the time of COVID-19: challenges for the Dakar Integrated Support Center for Addictions

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Résumé

          La pandémie de COVID-19 a eu un impact sur le fonctionnement des systèmes de santé dont les modes d’adaptation et de réponse sur le terrain sont encore peu documentés et en cours d’évolution. Le Centre de Prise en charge Intégrée des Addictions de Dakar (CEPIAD) met en œuvre depuis 2014 la réduction des risques auprès d’usagers de drogues. La pandémie de COVID-19 et les mesures de santé publique ont été un obstacle à sa fréquentation par les patients, notamment du fait de la limitation des déplacements. Outre la mise en place de mesures préventives et l’application des gestes barrières dans le centre, le CEPIAD a eu recours à l’emport à domicile de la méthadone habituellement dispensée chaque jour dans ses locaux. Le centre a aussi pris en charge des usagers de cannabis incarcérés après leur amnistie. Plusieurs aspects de l’expérience du CEPIAD, perçue positivement, pourraient être pertinents hors du contexte pandémique.

          Translated abstract

          The COVID-19 pandemic has an impact on health systems, whose modes of adaptation and response on the ground are still poorly documented and are evolving. The Dakar Integrated Support Center for Addictions (CEPIAD) has been implementing risk reduction since 2014, particularly with drug users. The COVID-19 pandemic and related public health measures were an obstacle to its attendance by patients, in particular due to movement restriction. In addition to the implementation of individual and collective preventive measures in the center, CEPIAD has experimented “take-home” for methadon that is generally provided daily through directly observed treatment. The center has also taken care of amnestied incarcerated cannabis users. Several aspects of this experience, perceived positively, could be relevant outside the pandemic context.

          Related collections

          Most cited references3

          • Record: found
          • Abstract: found
          • Article: not found

          Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies

          Hisham A. Badreldin, Bassam Atallah (2020)
          Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.
          Article 0 comments Cited 71 times – based on 0 reviews     Review now
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study

            Annie Leprêtre, Idrissa Ba, Karine Lacombe … (2015)
            Objectives Data on the extent of drug use and associated HIV, hepatitis C and hepatitis B infection in West Africa are lacking. The objectives of ANRS12244 UDSEN study were to estimate the size of the heroin and/or cocaine drug user (DU) population living in the Dakar area (Senegal), and assess the prevalence and risk factors of HIV, hepatitis C virus (HCV) and hepatitis B virus (HBV), including behavioural determinants in this population, in order to set up an integrated prevention and treatment programme for DUs. Design and methods A capture-recapture method was applied for population size estimation, whereas the respondent-driven sampling (RDS) method was used to recruit a sample of DUs living in the Dakar area and determine HIV, HBV and HCV prevalence. Behavioural data were gathered during face-to-face interviews, and blood samples were collected on dried blood spots for analysis in a central laboratory. Data analysis was performed using the RDS analysis tool, and risk factors were determined by logistic regression. Access to laboratory results was organized for the participants. Results The size of the DU population in the Dakar area was estimated to reach 1324 (95% confidence interval (95% CI: 1281–1367)). Based on the 506 DUs included in the study, the HIV, HCV and HBV prevalence were 5.2% (95% CI: 3.8–6.3), 23.3% (95% CI: 21.2–25.2) and 7.9% (95% CI: 5.2–11.1), respectively. In people who inject drugs (PWID), prevalence levels increased to 9.4% for HIV and 38.9% for HCV (p=0.001 when compared to those who never injected). Women were more at risk of being HIV infected (prevalence: 13.04% versus 2.97% in males, p=0.001). Being PWID was a risk factor for HCV and HIV infection (odds ratio, OR: 2.7, 95% CI: 1.7–4.3, and OR: 4.3, 95% CI: 1.7–10.7, respectively), whereas older age and female sex were additional risk factors for HIV infection (10% increase per year of age, p=0.03 and OR: 4.9, 95% CI: 1.6–156, respectively). No specific determinant was associated with the risk of HBV infection. Conclusions High HIV and HCV prevalence were estimated in this population of DUs (including non-injectors) living in the Dakar area, Senegal, whereas HBV prevalence was close to that of the global Senegalese population, reflecting a risk of infection independent of drug use. Women seem to be highly vulnerable and deserve targeted interventions for decreasing exposure to HIV, while behavioural risk factors for HIV and HCV include the use of unsafe injections, reflecting the urgent need for developing harm reduction interventions and access to opioid substitution therapy services.
            Article 0 comments Cited 14 times – based on 0 reviews     Review now
              • Record: found
              • Abstract: not found
              • Article: not found

              Besoins de soins médicaux des consommateurs de drogues injectables à Dakar: diagnostic, analyses et recommandations (Mémoire de Master 2 Santé publique et environnement)

              M. Clouzeau (2014)
              Article 0 comments Cited 1 times – based on 0 reviews     Review now
                All references

                Author and article information

                Journal
                Journal ID (nlm-ta): Med Trop Sante Int
                Journal ID (iso-abbrev): Med Trop Sante Int
                Journal ID (publisher-id): MTSI
                Title: Médecine Tropicale et Santé Internationale
                Publisher: MTSI
                ISSN (Print): 2778-2034
                ISSN (Electronic): 2778-2034
                Publication date Collection: 31 March 2021
                Publication date (Electronic): 18 February 2021
                Volume: 1
                Issue: 1
                Electronic Location Identifier: V3RB-PV49
                Affiliations
                [1 ]Centre de prise en charge intégrée des addictions de Dakar (CEPIAD), Sénégal
                [2 ]Université Cheikh Anta Diop de Dakar, Sénégal
                [3 ]Centre régional de recherche et de formation à la prise en charge du VIH et des maladies infectieuses (CRCF), CHUN de Fann, Dakar, Sénégal
                [4 ]Institut de recherche pour le développement, TransVIHMI, Dakar, Sénégal
                [5 ]Projet CODISOCS: Consommateurs de drogues injectables et dynamiques sociales au Sénégal, ANRS 12383
                [6 ]Service de psychiatrie, Centre hospitalier national universitaire de Fann (CHNUF), Dakar, Sénégal
                Author notes
                [1]

                ANRS 12334. Ce projet intitulé « Cohorte de consommateurs de Drogues Injectables au Sénégal » vise à examiner l’efficacité à moyen terme d’une prise en charge intégrée des usagers de drogues injectables.

                Article
                DOI: 10.48327/V3RB-PV49
                PMC ID: 9128414
                PubMed ID: 35685392
                SO-VID: 8c2dbe31-c564-40c3-8bde-8d9a31795efd
                Copyright © Copyright © 2021 SFMTSI
                License:

                Cet article en libre accès est distribué selon les termes de la licence Creative Commons CC BY 4.0 ( https://creativecommons.org/licenses/by/4.0/).

                History
                Page count
                Figures: 2, References: 10, Pages: 6
                Categories
                Subject: Sur Place

                Keywords: covid-19,usagers de drogues,services de santé,impact socio-sanitaire,sénégal,drug users,health services,socio-sanitary impact,senegal
                Data availability:
                Keywords: covid-19, usagers de drogues, services de santé, impact socio-sanitaire, sénégal, drug users, health services, socio-sanitary impact, senegal

                Comments

                Comment on this article

                Related Documents Log
                scite_

                Similar content190

                See all similar

                Most referenced authors24

                See all reference authors